{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T15:50:44Z","timestamp":1783612244467,"version":"3.55.0"},"reference-count":38,"publisher":"Tech Science Press","issue":"5","license":[{"start":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T00:00:00Z","timestamp":1713916800000},"content-version":"vor","delay-in-days":114,"URL":"https:\/\/doi.org\/10.32604\/TSP-CROSSMARKPOLICY"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["OR"],"published-print":{"date-parts":[[2024]]},"DOI":"10.32604\/or.2023.043922","type":"journal-article","created":{"date-parts":[[2024,1,31]],"date-time":"2024-01-31T03:36:55Z","timestamp":1706672215000},"page":"955-963","update-policy":"https:\/\/doi.org\/10.32604\/tsp-crossmarkpolicy","source":"Crossref","is-referenced-by-count":6,"title":["A genetic variant study of bortezomib-induced peripheral neuropathy in Chinese multiple myeloma patients"],"prefix":"10.32604","volume":"32","author":[{"given":"YAN","family":"ZHANG","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HEYANG","family":"ZHANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JING","family":"WANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"XIN","family":"WEI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YI","family":"QU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"FENG","family":"XU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LIJUN","family":"ZHANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"17807","published-online":{"date-parts":[[2024]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S0140-6736(21)00135-5","article-title":"Multiple myeloma","volume":"397","author":"van de Donk","year":"2021","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1080\/10428194.2018.1493727","article-title":"Targeting the cross-talk between the hedgehog and NF-\u03baB signaling pathways in multiple myeloma","volume":"60","author":"Cai","year":"2019","journal-title":"Leukemia & Lymphoma"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s10555-017-9707-8","article-title":"The proteasome and proteasome inhibitors in multiple myeloma","volume":"36","author":"Gandolfi","year":"2017","journal-title":"Cancer Metastasis Reviews"},{"key":"ref4","first-page":"341","article-title":"The guidelines for the diagnosis and management of multiple myeloma in China (2020 revision)","volume":"59","year":"2020","journal-title":"Chinese Journal of Internal Medicine"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1744806918797042","DOI":"10.1177\/1744806918797042","article-title":"Clinical, electrophysiological, and cutaneous innervation changes in patients with bortezomib-induced peripheral neuropathy reveal insight into mechanisms of neuropathic pain","volume":"14","author":"Bechakra","year":"2018","journal-title":"Molecular Pain"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1529-8027.2010.00248.x","article-title":"Neurological monitoring reduces the incidence of bortezomib-induced peripheral neuropathy in multiple myeloma patients","volume":"15","author":"Velasco","year":"2010","journal-title":"Journal of the Peripheral Nervous System"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.clml.2017.06.035","article-title":"Evaluation of bortezomib-induced neuropathy using total neuropathy score (reduced and clinical versions) and NCI CTCAE v4.0 in newly diagnosed patients with multiple myeloma receiving Bortezomib-based induction","volume":"17","author":"Lakshman","year":"2017","journal-title":"Clinical Lymphoma, Myeloma & Leukemia"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.bulcan.2018.07.009","article-title":"Neuropathies p\u00e9riph\u00e9riques chimio-induites: Symptomatologie et \u00e9pid\u00e9miologie","volume":"105","author":"Kerckhove","year":"2018","journal-title":"Bulletin du Cancer"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1146\/annurev-pharmtox-030920-025745","article-title":"Challenges and opportunities in implementing pharmacogenetic testing in clinical settings","volume":"61","author":"Chang","year":"2021","journal-title":"Annual Review of Pharmacology and Toxicology"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1002\/hon.2337","article-title":"Prediction of peripheral neuropathy in multiple myeloma patients receiving bortezomib and thalidomide: A genetic study based on a single nucleotide polymorphism array","volume":"35","author":"Garc\u00eda-Sanz","year":"2017","journal-title":"Hematological Oncology"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1111\/jns.12338","article-title":"Bortezomib and other proteosome inhibitors-induced peripheral neurotoxicity: From pathogenesis to treatment","volume":"24","author":"Velasco","year":"2019","journal-title":"Journal of the Peripheral Nervous System"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.3892\/ol.2015.3294","article-title":"Effect of CYP2C19 and CYP3A4 gene polymorphisms on the efficacy of bortezomib-based regimens in patients with multiple myeloma","volume":"10","author":"Zhou","year":"2015","journal-title":"Oncology Letters"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1186\/1471-2407-10-404","article-title":"No influence of the polymorphisms CYP2C19 and CYP2D6 on the efficacy of cyclophosphamide, thalidomide, and bortezomib in patients with Multiple Myeloma","volume":"10","author":"Vangsted","year":"2010","journal-title":"BMC Cancer"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s11064-016-2007-9","article-title":"Genetic susceptibility to bortezomib-induced peripheral neuroropathy: Replication of the reported candidate susceptibility loci","volume":"42","author":"Campo","year":"2017","journal-title":"Neurochemical Research"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/FPC.0b013e3283436b45","article-title":"Genetic variation associated with bortezomib-induced peripheral neuropathy","volume":"21","author":"Favis","year":"2011","journal-title":"Pharmacogenetics and Genomics"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.3324\/haematol.2011.041434","article-title":"Genetic factors underlying the risk of bortezomib induced peripheral neuropathy in multiple myeloma patients","volume":"96","author":"Corthals","year":"2011","journal-title":"Haematologica"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"4350","DOI":"10.1158\/1078-0432.CCR-15-3163","article-title":"A Genome-wide association study identifies a novel locus for bortezomib-induced peripheral neuropathy in european patients with multiple myeloma","volume":"22","author":"Magrangeas","year":"2016","journal-title":"Clinical Cancer Research"},{"key":"ref18","unstructured":"Common Terminology Criteria for Adverse Events (CTCAE) (2017). CTCAE_v5_Quick_Reference_5x7. pdf. https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/ctc.htm (accessed on 01\/05\/2019)"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s00280-008-0876-6","article-title":"Central and peripheral nervous system toxicity of common chemotherapeutic agents","volume":"63","author":"Sioka","year":"2009","journal-title":"Cancer Chemotherapy and Pharmacology"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1182\/blood-2008-04-149385","article-title":"Bortezomib-induced peripheral neuropathy in multiple myeloma: A comprehensive review of the literature","volume":"112","author":"Argyriou","year":"2008","journal-title":"Blood"},{"key":"ref21","first-page":"435","article-title":"Toxic peripheral neuropathy associated with commonly used chemotherapeutic agents","volume":"15","author":"Argyriou","year":"2010","journal-title":"Journal of BUON"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1146\/annurev.med.56.082103.104724","article-title":"Pharmacogenomics and individualized drug therapy","volume":"57","author":"Eichelbaum","year":"2006","journal-title":"Annual Review of Medicine"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S1470-2045(10)70206-0","article-title":"Mechanisms of peripheral neuropathy associated with bortezomib and vincristine in patients with newly diagnosed multiple myeloma: A prospective analysis of data from the HOVON-65\/GMMG-HD4 trial","volume":"11","author":"Broyl","year":"2010","journal-title":"The Lancet Oncology"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"511","DOI":"10.3988\/jcn.2019.15.4.511","article-title":"Prediction of chemotherapy-induced peripheral neuropathy in patients with lymphoma and myeloma: The roles of brain-derived neurotropic factor protein levels and a gene polymorphism","volume":"15","author":"Azoulay","year":"2019","journal-title":"Journal of Clinical Neurology"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/hon.2391","article-title":"Bortezomib-induced peripheral neuropathy: A genome-wide association study on multiple myeloma patients","volume":"36","author":"Campo","year":"2018","journal-title":"Hematological Oncology"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"639","DOI":"10.2217\/pgs.09.12","article-title":"Predicting potentially functional SNPs in drug-response genes","volume":"10","author":"Pang","year":"2009","journal-title":"Pharmacogenomics"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"e22401","DOI":"10.1002\/jcla.22401","article-title":"Opposite impact of methylene tetrahydrofolate reductase C677T and Methylene tetrahydrofolate reductase A1298C gene polymorphisms on systemic inflammation","volume":"32","author":"Khalighi","year":"2018","journal-title":"Journal of Clinical Laboratory Analysis"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1600351","DOI":"10.1002\/mnfr.201600351","article-title":"Influence of food groups on plasma total homocysteine for specific MTHFR C677T genotypes in Chinese population","volume":"61","author":"Zeng","year":"2017","journal-title":"Molecular Nutrition & Food Research"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s10072-009-0013-2","article-title":"Subacute combined degeneration of the spinal cord caused by nitrous oxide anaesthesia","volume":"30","author":"Renard","year":"2009","journal-title":"Neurological Sciences"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"S803","DOI":"10.1016\/j.dsx.2017.06.002","article-title":"Association between insulin resistance and total plasma homocysteine levels in type 2 diabetes mellitus patients in south west Nigeria","volume":"11","author":"Ala","year":"2017","journal-title":"Diabetes & Metabolic Syndrome"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12986-017-0233-z","article-title":"The metabolism and significance of homocysteine in nutrition and health","volume":"14","author":"Kumar","year":"2017","journal-title":"Nutrition & Metabolism"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"3828","DOI":"10.1158\/0008-5472.CAN-04-3684","volume":"65","author":"Landowski","year":"2005","journal-title":"Cancer Research"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"153410","DOI":"10.1016\/j.phymed.2020.153410","volume":"81","author":"Ji","year":"2021","journal-title":"Phytomedicine"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.cell.2011.11.034","article-title":"SnapShot: Retinoic acid signaling","volume":"147","author":"Kumar","year":"2011","journal-title":"Cell"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1097\/00008571-200111000-00007","article-title":"Organization, structure and evolution of the CYP2 gene cluster on human chromosome 19","volume":"11","author":"Hoffman","year":"2001","journal-title":"Pharmacogenetics"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3390\/ijms22010013","article-title":"The multifaceted role of epoxide hydrolases in human health and disease","volume":"22","author":"Gautheron","year":"2020","journal-title":"International Journal of Molecular Sciences"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3390\/ijms21020505","article-title":"Role of the serotonin receptor 7 in brain plasticity: From development to disease","volume":"21","author":"Crispino","year":"2020","journal-title":"International Journal of Molecular Sciences"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1002\/acn3.50868","article-title":"Variants in MME are associated with autosomal-recessive distal hereditary motor neuropathy","volume":"6","author":"Hong","year":"2019","journal-title":"Annals of Clinical and Translational Neurology"}],"container-title":["Oncology Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.techscience.com\/files\/or\/2024\/TSP_OR-32-5\/OncolRes-32-05-43922\/OncolRes-32-43922.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T07:29:31Z","timestamp":1741246171000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.techscience.com\/or\/v32n5\/56245"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":38,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024]]},"published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.32604\/or.2023.043922","relation":{},"ISSN":["1555-3906"],"issn-type":[{"value":"1555-3906","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"2023-07-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-12-05","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-23","order":2,"name":"published","label":"Published Online","group":{"name":"publication_history","label":"Publication History"}}]}}